QLY Biotech Group Corp.
LQLY
$1.00
-$0.06-5.66%
OTC PK
| 02/28/2023 | 11/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.09% | 91.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.09% | 91.67% | |||
| Operating Income | -26.09% | -91.67% | |||
| Income Before Tax | -26.09% | -91.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -26.09% | -91.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.09% | -91.67% | |||
| EBIT | -26.09% | -91.67% | |||
| EBITDA | -27.47% | -89.58% | |||
| EPS Basic | -25.00% | -100.00% | |||
| Normalized Basic EPS | -26.67% | -87.50% | |||
| EPS Diluted | -25.00% | -100.00% | |||
| Normalized Diluted EPS | -26.67% | -87.50% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||